
|Articles|December 1, 2012
Dermatology Times, Digital Edition, December 2012
Maximizing the Money : Amid increasing competition, group purchasing and similar programs allow dermatologists to do more with less Anti-fraud campaign could trigger wave of audits, experts warn Clinical Dermatology : Systemic options for severe atopic dermatitis continue to present challenges Cosmetic Dermatology : Uncovering the truth about antioxidants and how they work Cutaneous Oncology : Clinicopathologic correlation weeds out mimickers of lymphoma Practice Management : Document your E/M services correctly to obtain optimal reimbursement
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review
2
UCB Presents 3-Year BE HEARD Trial Results for Bimekizumab in Moderate-to-Severe HS
3
Kicking Off MOPD 2026 With Lawrence Schachner, MD
4
Sagimet and Ascletis Report Positive 52-Week Safety and Efficacy Data for Denifanstat in Acne
5











